alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.1

                           SECTION 302 CERTIFICATION

I, Mark A. Smith, certify that:

1.   I have reviewed this quarterly report on Form 10-QSB of Bion
Environmental Technologies, Inc.;

2.   Based on my knowledge, this report does not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;

3.   Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
of the small business issuer as of, and for, the periods presented in this
report;

4.   I am responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for
the small business issuer and have:

     (a)  Designed such disclosure controls and procedures or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the small business issuer,
including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being
prepared;

     (b)  Evaluated the effectiveness of the small business issuer's
disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report based on such
evaluation; and

     (c)  Disclosed in this report any change in the small business issuer's
internal control over financial reporting that occurred during the small
business issuer's most recent fiscal quarter (the small business issuer's
fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the small business
issuer's internal control over financial reporting; and

5.   I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the small business issuer's auditors and
the audit committee of the small business issuer's board of directors (or
persons performing the equivalent functions):

     (a)  All significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are
reasonably likely to adversely affect the small business issuer's ability to
record, process, summarize and report financial information; and



     (b)  Any fraud, whether or not material, that involves management or
other employees who have a significant role in the small business issuer's
internal control over financial reporting.

Date: May 7, 2008



/s/ Mark A. Smith
Mark A. Smith
Chief Executive Officer and
Principal Financial Officer
Exhibit
32.1






CERTIFICATION
PURSUANT TO


18
U.S.C. Section 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002






In
connection with the Annual Report of Great Walll Builders Ltd., (the "Company")
on Form 10-K for the period ended June 30st, 2009 as filed with the
Securities and Exchange Commission on the date here of (the "report"), I, Tian
Jia, Chief Executive Officer and Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:




(1)  The Report fully
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and




(2)  The information
contained in this Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.




Dated:
Nov.10, 2009






Great
Wall Builders Ltd.,






/s/ Tian Jia


Tian
Jia




Chief
Executive Officer & Chief Financial Officer
No. 67127.

protests 60/4805, etc. (San Francisco).

#### Filetta Fish, A/S, et al. *v.*United States,

Opinion by

Wilson, J.

In accordance with stipulation of counsel that the merchandise consists of fish similar in all material respects to the fish blocks the subject of *The Lee Herrmann Co., a/c The Coldwater Seafood Corp.*v. *United States*(43 Cust. Ct. 49, C.D. 2101), the claim of the plaintiffs was sustained.
I N THE SUPREME COURT OF PENNSYLVANIA MIDDLE DISTRICT

**IN THE INTEREST OF: D.Y.S. & E.M.S.**

**PETITION OF: T.J.H., NATURAL MOTHER**  **:**

**:**

**:**

**:**

**: No. 924 MAL 2015** 

**P etition for Allowance of Appeal from**  **the Order of the Superior Court**

ORDER

P ER CURIAM

AND NOW **, this 19th day of January, 2016, the Petition for Allowance of Appeal**

**is** DENIED

**. Mr. Justice Eakin did not participate in the consideration or decision of this** 

**matter.**
No. 60558.

#### Samuel Shapiro & Co., Inc. *v.*United States,

protest 289834-K (Baltimore).

Opinion by

Lawrence, J.

There being nothing before the court tending in any way to overcome the presumption of correctness attaching to the classification by the collector, the protest was overruled.
1 The Honorable John F. Forster, Jr., United States Magistrate Judge for the Eastern District of Arkansas, to whom the case was referred for final disposition by consent of the parties pursuant to 28 U.S.C. § 636(c). 

## United States Court of Appeals FOR THE EIGHTH CIRCUIT

___________ No. 03-3142

___________ Janice E. Buddemeier, * * Appellant, * * Appeal from the United States v. * District Court for the * Eastern District of Arkansas. Jo Anne B. Barnhart, Commissioner, * Social Security Administration, * [UNPUBLISHED] * Appellee. *

___________ Submitted: April 6, 2004 Filed: April 22, 2004

___________ Before MELLOY, HANSEN, and COLLOTON, Circuit Judges.

___________ PER CURIAM. Janice Buddemeier appeals the district court’s 1 order dismissing her challenge to the Commissioner’s denial of disability insurance benefits. We affirm.-2- The Commissioner denied Buddemeier benefits in 1986 because her condition would not keep her from working for 12 consecutive months. In 1995, at Buddemeier’s request, her case was reopened, but the Commissioner again denied benefits. An administrative law judge found in 1999 that the case was improperly reopened, and reinstated the 1986 denial as the final agency determination. When Buddemeier sought judicial review, the district court found that it lacked jurisdiction to hear the case. Upon de novo review, see Boock v. Shalala , 48 F.3d 348, 351 & n.2 (8th Cir. 1995), we conclude dismissal was proper b ecause the Commissioner’s refusal to reconsider a previously denied claim is not a “final order” and is unreviewable absent a constitutional violation, see Robertson v. Sullivan , 979 F.2d 623, 625 (8th Cir. 1992) (per curiam). Accordingly, we affirm the judgment of the district court.

______________________________
Exhibit 32.1  CERTIFICATION OF CHIEF EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the Annual Report of The Connect Corp. (the Company) on Form 10-K for the period ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Ken Waters, acting Principal Executive and Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sect. 1350, as adopted pursuant to Sect. 906 of the Sarbanes-Oxley Act of 2002, that: (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. IN WITNESS WHEREOF, the undersigned has executed this certification as of the 15th day of April, 2011.  /s/ Ken Waters Ken Waters Acting Principal Executive Officer and Financial Officer
[Federal Register Volume 88, Number 190 (Tuesday, October 3, 2023)]
[Notices]
[Page 68097]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21826]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Order No. 2152]


Designation of New Grantee; Foreign-Trade Zone 47; Boone County, 
Kentucky

    Pursuant to its authority under the Foreign-Trade Zones Act of 
June 18, 1934, as amended (19 U.S.C. 81a-81u), the Foreign-Trade 
Zones Board (the Board) adopts the following Order:

    The Foreign-Trade Zones (FTZ) Board (the Board) has considered the 
application (docketed June 20, 2023) submitted by the Greater 
Cincinnati Foreign Trade Zone, Inc., grantee of FTZ 47, requesting 
reissuance of the grant of authority for said zone to the Northern 
Kentucky Foreign Trade Zone, Inc., which has accepted such reissuance 
subject to approval by the FTZ Board. Upon review, the Board finds that 
the requirements of the FTZ Act and the Board's regulations are 
satisfied, and that the proposal is in the public interest.
    Therefore, the Board approves the application and recognizes the 
Northern Kentucky Foreign Trade Zone, Inc. as the new grantee for 
Foreign-Trade Zone 47, subject to the FTZ Act and the Board's 
regulations, including section 400.13.

    Dated: September 27, 2023.
Lisa W. Wang,
Assistant Secretary for Enforcement and Compliance, Alternate Chairman, 
Foreign-Trade Zones Board.
[FR Doc. 2023-21826 Filed 10-2-23; 8:45 am]
BILLING CODE 3510-DS-P
No. 63847.

protest 58/15075 (New York).

#### Quality Importers, Inc. *v.*United States,

Opinion by

Johnson, J.

It was stipulated that the facts and issues herein are similar in all material respects to those involved in *United States*v. *Browne Vintners Co., Inc.*(34 C.C.P.A. 112, C.A.D. 351) and that the quantities reported by the inspector as manifested, not found, were not in fact received by the importer. In accordance with stipulation of counsel and following the decision cited, it was held that duty and internal revenue tax are not assessable upon such portions of the merchandise as were reported by the inspector as manifested, not found. The protest was sustained to this extent.
Before the Third Division,

October 24, 1966

No. P66/296. —

#### Arnart Imports, Inc. *v.*United States, protests 59/10875, etc. (New York).

Landis, J.

In accordance with stipulation of counsel that the items of merchandise marked “W” covered by the foregoing protests consist of plaques similar in all material respects to those the subject of *Arnart Imports, Inc.*v. *United States*(54 Cust. Ct. 187, C.D. 2531), and that the items of merchandise marked “T” covered by the foregoing protests consist of cups and saucers similar in all material respects to those the subject of *W. Kay Company, Inc.*v. *United States*(53 Cust. Ct. 130, C.D. 2484), the claims of the plaintiffs were sustained.
No. 67562.

#### Manca, Inc. *v.*United States,

protest 61/10391 (New York).

Opinion by

Oliveb, C.J.

In accordance with stipulation of counsel that the articles, described on the invoice as “Monla lamps,” are lamps provided with a special stand of their own; that they can be used not only as light source for microscopes, but also as light source for a great many other devices; and that they have no special fittings for the purpose of attaching them to a microscope, the claim of the plaintiff was sustained.
[Federal Register Volume 88, Number 190 (Tuesday, October 3, 2023)]
[Notices]
[Page 68128]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21772]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Allergy, Immunology, and 
Transplantation Research Committee (AITC) Special Emphasis Panel.
    Date: November 1, 2023.
    Time: 10:30 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G45, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Vanitha S. Raman, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G45, 
Rockville, MD 20852, 301-761-7949, <a href="/cdn-cgi/l/email-protection#6513040b0c110d044b170408040b250b0c0d4b020a13"><span class="__cf_email__" data-cfemail="5b2d3a35322f333a75293a363a351b353233753c342d">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 27, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-21772 Filed 10-2-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
##### 



Exhibit 31.1
 CERTIFICATION
PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
  1.
    
    I have reviewed this quarterly report on Form 10-Q of SPARTA, Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this
report;4.
    
    The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) for the registrant and have:
 a)
    
    Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is
made known to us by others within those entities, particularly during the period in
which this report is being prepared;b)
    
    Evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report
based on such evaluation; andc)
    
    Disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal quarter
(the registrants fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the registrants
internal control over financial reporting; and
 5.
    
    The registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of registrants board of directors (or persons performing the equivalent
functions):
 a)
    
    All significant deficiencies and material weaknesses in the design or operation
of internal control over financial reporting which are reasonably likely to adversely
affect the registrants ability to record, process, summarize and report financial
information; andb)
    
    Any fraud, whether or not material, that involves management or other employees
who have a significant role in the registrants internal control over financial
reporting.
  /s/ Robert C. Sepucha

Robert C. SepuchaChief Executive Officer(Principal Executive Officer)
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Allergy, Immunology, and Transplantation Research Committee (AITC) Special Emphasis Panel.                    

*Date:*                         November 1, 2023.                    

*Time:*                         10:30 a.m. to 12:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G45, Rockville, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Vanitha S. Raman, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities,  National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G45, Rockville, MD 20852, 301-761-7949,                         *vanitha.raman@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: September 27, 2023.

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2023-21772 Filed 10-2-23; 8:45 am]

BILLING CODE 4140-01-P
From: bruce4610@gmail.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 9:35:28 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Bruce Peters

Coal Valley, IL 61240
**Exhibit 32.2**

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Northern Technologies International Corporation (the “Company”) on Form 10-QSB for the period ending February 28, 2007 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Matthew C. Wolsfeld, Chief Financial Officer and Corporate Secretary of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

|                                                                  |   |
|------------------------------------------------------------------|--------|
|                                                                  |   |
| Matthew   C. Wolsfeld, CPA                                       |   |
| Chief   Financial Officer and Corporate Secretary                |   |
| (principal   financial officer and principal accounting officer) |   |
|                                                             |   |
|                                                             |   |
| Circle Pines, Minnesota                                          |   |
| April 11, 2007                                                   |   |